Joshua Rosenow MD

Dr. Joshua M. Rosenow is the Director of Functional Neurosurgery and Professor of Neurosurgery, Neurology, and Physical Medicine and Rehabilitation in the Northwestern University Feinberg School of Medicine. He specializes in the surgical treatment of movement disorders such as Parkinson’s disease, tremor, and dystonia, as well as the surgical treatment of epilepsy and chronic pain.
Dr. Rosenow graduated from Yale University School of Medicine, completed neurosurgical training at New York Medical College, and received a fellowship in stereotactic, functional, restorative neurosurgery and epilepsy surgery at the Cleveland Clinic Foundation. He was awarded the 2003 Ronald Tasker award for pain research by the AANS/CNS Joint Section on Pain. He was one of the members of the team that developed frameless deep-brain stimulation surgery. In addition, he was one of the founding members of the Functional Neurosurgery Working Group of the Parkinson’s Study Group.

He is a past Chair of both the AANS/CNS Joint Section on Pain and the Council of State Neurosurgical Societies. He has been an elected member of the Executive Council of the ASSFN and the Board of Directors of NANS. He has served as President of the Illinois State Neurosurgical Society. He is an elected fellow of the American College of Surgeons and a frequent lecturer and instructor at national and international neurosurgical meetings.

Dr. Rosenow serves organized Neurosurgery as an alternate advisor to the AMA CPT panel and works with Neurosurgery’s Washington staff and regionally with insurers to advocate for policies to expand and maintain access to advanced neurosurgical therapies. He is the Chair of the AANS/CNS Drugs and Devices Committee and Chair of the neurosurgical delegation to the AMA House of Delegates.

Dr. Rosenow currently conducts research into the areas of stereotactic and image-guided surgery, neurostimulation for the enhancement of neurologic recovery after brain injury and stroke, imaging biomarkers in pain, socioeconomic factors in neurosurgery and neuromodulation, opioid policy, exploration of brain function using implanted electrodes, brain-machine interface, and new devices for the treatment of neurologic disorders. He has been the site PI for numerous national clinical trials of novel therapies such as new implantable devices, gene therapy, and stem cell products for the treatment of neurologic diseases.